Tyrocidine B1, TrcB1
General Information
DRACP ID DRACP02271
Peptide Name Tyrocidine B1, TrcB1
Sequence VKLfPWfNQY
Sequence Length 10
UniProt ID Not available
PubChem CID 45485348
Origin Bacillus aneurinolyticus; Bacillus brevis
Type Native peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | LC50=28 µM | Resazurin assay | 24 h | 1 |
A549 | Lung adenocarcinoma | Carcinoma | LC50=24 µM | Resazurin assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis=8.6 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond NCB: Val1<--->Tyr10
N-terminal Modification Free
C-terminal Modification Free
Other Modification f=D-Phe
Chiral Mix
Physicochemical Information
Formula C51H70N12O10
Absent amino acids ACDEFGHIMRST
Common amino acids KLNPQVWY
Mass 117190
Pl 9.3
Basic residues 1
Acidic residues 0
Hydrophobic residues 3
Net charge 1
Boman Index -658
Hydrophobicity -67
Aliphatic Index 68
Half Life
/
Extinction Coefficient cystines 6990
Absorbance 280nm 776.67
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 17462586
Title Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis
Doi 10.1016/j.bbamem.2007.01.015
Year 2007
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPN_6092